Table 1.
Patient demographics and clinical characteristics
| Number of patients, n | 60 |
| Age, years | 60 [48–68] |
| Female, n (%) | 20 (33) |
| Height, cm | 174 ± 9 |
| Weight, kg | 79 ± 15 |
| BMI, kg/m2 | 26 ± 4 |
| BSA, m2 | 1.95 ± 0.23 |
| Systolic blood pressure, mmHg | 127 ± 20 |
| Diastolic blood pressure, mmHg | 74 ± 9 |
| Heart rate, beats per minute | 65 [59–81] |
| Smoking | |
| Never smoked, n (%) | 40 (67) |
| Former smoker, n (%) | 16 (27) |
| Current smoker, n (%) | 4 (7) |
| Drugs | |
| Beta-blocker, n (%) | 40 (67) |
| Angiotensin receptor blocker, n (%) | 9 (15) |
| Calcium channel blocker, n (%) | 10 (17) |
| Diuretic, n (%) | 17 (28) |
| Angiotensin converting enzyme inhibitor, n (%) | 16 (28) |
| Ticagrelor or clopidogrel, n (%) | 17 (29) |
| Warfarin, n (%) | 5 (8) |
| Diagnosis by CMR | |
| Ischemic myocardial disease, n (%) | 18 (30) |
| Acute myocardial infarction, n (%) | 11 (18) |
| Dilated cardiomyopathy, n (%) | 6 (10) |
| Hypertrophic cardiomyopathy, n (%) | 5 (8) |
| Amyloidosis, n (%) | 2 (3) |
| Myocarditis, n (%) | 3 (5) |
| Pericarditis, n (%) | 3 (5) |
| Normal findings, n (%) | 3 (5) |
| Other, n (%) | 6 (10) |
| NYHA class | |
| 0 | 38 (63) |
| 1 | 12 (20) |
| 2 | 5 (8) |
| 3 | 5 (8) |
| 4 | 0 (0) |
Continuous variables reported as mean ± standard deviation if normally distributed, otherwise reported as median [interquartile range]. Categorical variables reported as n (% of total)